AZN vs INGN · P/E 28, $288.38B cap vs rev $180.2M
AstraZeneca PLC (AZN) versus Inogen Inc (INGN) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Inogen Inc (INGN) is a medical devices company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported INGN revenue for 2026-06-30 was $180.2M. Net income was -$12.2M. INGN currently screens at market cap $173.5M.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. INGN currently screens at market cap $173.5M.
Not investment advice. Open the AZN and INGN stock pages for the full models.
Not investment advice.